Title: Dermato-Epidemiological Profile and HIV Seropositivity among Male Patients with Herpes Zoster
Authors: Col (Dr) Sehdev Singh, Maj (Dr) Shekhar Neema, Lt Col (Dr) Niloy Pathak
DOI: https://dx.doi.org/10.18535/jmscr/v5i5.152
Abstract
Background: Herpes zoster represents reactivation of the latent varicella-zoster virus in the sensory ganglia and forms a small subset of patients attending skin OPD. The study was conducted in Herpes zoster patients to find out the dermato-epidemiological profile and HIV (Human immunodeficiency virus) seropositivity among these cases.
Methods: Three hundred and sixty consecutive cases of Herpes zoster were recruited in the descriptive study over the period of three years. The diagnosis was based on the history and clinical examination. HIV screening was done by ELISA method in all the cases.
Results: The most common prodromal symptom was paresthesia seen in 22.5% followed by tingling in 17.5% of the cases. Most common presenting complaint was pain in 92.22% followed by localized itching in 6.12% of the patients. Classical herpes zoster were observed in 96-66% and necrotic/ulcerated and hemorrhagic lesions were seen in 3.34% cases only. Thoracic dermatome was the most frequently involved dermatome seen in 74.44% of the patients. Unidermatomal and multidermatomal involvement were noticed in 55.83% and 44.17% of the patients respectively. The seropositivity for HIV were found in 3.05% cases
Conclusion: Herpes zoster is a common cause of morbidity in younger population with commonest prodromal symptom of paresthesia and presenting symptom of pain. Though, unidermatomal involvement was more common, incidence of multidermatomal involvement was recorded much higher than earlier studies. HIV seropositivity has been recorded lower than reported incidence in the earlier studies.
Keywords: Herpes zoster; Dermatomes; seropositivity.
References
1. Straus SE, Schmader KE, Oxman MN. In: Freedberg M, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, editors. Fitzpatrick's Dermatology in General Medicine. 6th edition. New York: McGraw Hill, 2003; 2070-85.
2. Colebunders R, Mann JM, Francis H, et al. Herpes Zoster in African patients: A clinical predictor of human immune-deficiency virus infection. J Infect Dis 1988; 157(2): 314 -8.
3. Talwar S, Shrivastava VK. Herpes zoster ophthalmicus with total ophthalmoplegia. Indian J Dermatol Venereol Leprol 1991; 56: 454-5.
4. Talwar S. Herpes zoster associated with varicelliform eruption. Indian J Dermatol Venereol Leprol 1991; 57:62.
5. Ragozzino MW, Melton LJ III, Kurland LT et al. Population-based study of herpes zoster and its sequelae. Medicine (Baltimore) 1982; 61: 310-16.
6. Brisson M, Edmunds W, Law B, et al. Epidemiology of varicella zoster virus infection in Canada and the United King-dom. EpidemiolInfect.2001;127(2):305-14
7. Buchbinder SP, Katz M,Hessol N, et al. Herpes zoster and human immunod-eficiency virus infection. J Infect Dis. 1992;166(5):1153–56.
8. Hope-Simpson RE. The nature of herpes zoster: a long-term study and a new hypo-thesis. Proc R Soc Med. 1965;58:9-20.
9. Adams RD, Victor M, Ropper AH, editors. Sydromes of Herpes Zoster. In: Priciples of Neurology, International edition. New York: Mc-Graw Hill 1997;756-9.
10. Ragozzino MW, Melton LJ, Kurland LT. Population based study of herpes zoster and its sequelae. Medicine (Baltimore) 1982; 6: 310 - 16.
11. Donahue JG,Choo PW, Manson JE, Platt R. The incidence of herpes zoster. Arch Intern Med. 1995;155(15):1605–09.
12. Dubey Anand Kumar, Jaisankar T J, Thappa Devinder Mohan. Clinical and morphological characteristics of herpes zoster in south India. Indian J of Dermatology 2005; 04: 203-7.
13. Goh CL, Khoo L. A retrospective study of the clinical presentation and outcome of herpes zoster in a tertiary dermatology outpatient referral clinic. Int J Dermatol 1997; 36:667-72.
14. Kar PK, Ramasastry CV. HIV prevalence in patients with herpes zoster. Indian J of Dermatology, Venereology and Leprology 2003; 69:116-19.